Oncopeptides Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 127.5%.

Top 22 shareholders own 31.76% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.7%	Odlander, Fredrikson & Co. AB	27,296,255	SEK 41.2m	0%	3.52%
6.48%	Avanza Fonder AB	13,936,083	SEK 21.0m	0%	0.03%
4.85%	Nordnet Pensionsförsäkring Ab, Asset Management Arm	10,438,896	SEK 15.8m	-0.46%	0.29%
3.85%	Industrifonden	8,285,258	SEK 12.5m	0%	1.79%
2.1%	Handelsbanken Asset Management	4,520,183	SEK 6.8m	0%	no data
0.5%	SEB Investment Management AB	1,068,552	SEK 1.6m	0%	no data
0.4%	Jakob Lindberg	868,331	SEK 1.3m	0%	no data
0.24%	Storebrand Fonder AB,	526,824	SEK 795.5k	0%	no data
0.23%	Per Wold-Olsen	497,616	SEK 751.4k	0%	no data
0.16%	FCG Fonder AB	347,456	SEK 524.7k	0%	0.01%
0.065%	Skandia Fonder AB	140,274	SEK 211.8k	0%	no data
0.056%	Eva Nordström	120,200	SEK 181.5k	0%	no data
0.047%	Jarl Jungnelius	101,042	SEK 152.6k	0%	no data
0.046%	Klaas Bakker	100,000	SEK 151.0k	0%	no data
0.026%	Cecilia Wennborg	55,092	SEK 83.2k	0%	no data
0.0093%	Sofia Heigis	20,104	SEK 30.3k	0%	no data
0.004%	Fund Development & Advisory AG	8,500	SEK 12.8k	0%	no data
0.0031%	State Street Global Advisors, Inc.	6,747	SEK 10.2k	12.6%	no data
0.002%	Danske Bank A/S, Asset Management Arm	4,326	SEK 6.5k	133%	no data
0.0019%	Deutsche Asset & Wealth Management	4,000	SEK 6.0k	0%	no data
0.0002%	Nordea Investment Management, AB	437	SEK 649.9	0%	no data
0.00004%	Sara Svardgren	85	SEK 130.0	0%	no data